Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Hachulla

Showing results (151-160 of 506) with videos related to

Pageof 51
Sort By:
RMD Open|June 15, 2023
Assessment of type I interferon response in routine practice in France in 2022Anais Nombel, Anne Perrine Foray, Lorna Garnier, et al.
Arthritis Research & Therapy|March 4, 2021
Safety and efficacy of low-dose intravenous arsenic trioxide in systemic lupus erythematosus: an open-label phase IIa trial (Lupsenic)Mohamed Hamidou, Antoine Néel, Joel Poupon, et al.
RMD Open|September 16, 2022
Outcome of COVID-19 in patients with rheumatic and inflammatory diseases treated with mycophenolic acid: data from the French RMD COVID-19 cohortMarie-Elise Truchetet, Elodie Drumez, Thomas Barnetche, et al.
Frontiers in Immunology|July 19, 2019
Renal Pathologic Findings in TAFRO Syndrome: Is There a Continuum Between Thrombotic Microangiopathy and Membranoproliferative Glomerulonephritis? A Case Report and Literature ReviewAmélie Leurs, Viviane Gnemmi, Arnaud Lionet, et al.
British Journal of Haematology|November 20, 2002
Autologous bone marrow transplantation in the treatment of refractory systemic sclerosis: early results from a French multicentre phase I-II studyDominique Farge, Jean Pierre Marolleau, Sarah Zohar, et al.
BMC Nephrology|November 11, 2018
Early predictors of one-year mortality in patients over 65 presenting with ANCA-associated renal vasculitis: a retrospective, multicentre studyDimitri Titeca-Beauport, Alexis Francois, Thierry Lobbedez, et al.
Clinical Rheumatology|February 4, 2014
Risk factors for severe bacterial infections in patients with systemic autoimmune diseases receiving rituximabMarion Heusele, Pierre Clerson, Benoit Guery, et al.
The Journal of Rheumatology|June 3, 2009
Clinical features of scleroderma patients with or without prior or current ischemic digital ulcers: post-hoc analysis of a nationwide multicenter cohort (ItinérAIR-Sclérodermie)Kiet Phong Tiev, Elisabeth Diot, Pierre Clerson, et al.
Presse Medicale (Paris, France : 1983)|November 23, 2007
[Management of digital ulcers from systemic scleroderma]Camille Francès, Yannick Allanore, Jean Cabane, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 11, 2019
Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic SclerosisVincent Sobanski, Jonathan Giovannelli, Yannick Allanore, et al.
Pageof 51

Showing results (151-160 of 506) with videos related to

Sort By:
Pageof 51
RMD Open|June 15, 2023
Assessment of type I interferon response in routine practice in France in 2022Anais Nombel, Anne Perrine Foray, Lorna Garnier, et al.
Arthritis Research & Therapy|March 4, 2021
Safety and efficacy of low-dose intravenous arsenic trioxide in systemic lupus erythematosus: an open-label phase IIa trial (Lupsenic)Mohamed Hamidou, Antoine Néel, Joel Poupon, et al.
RMD Open|September 16, 2022
Outcome of COVID-19 in patients with rheumatic and inflammatory diseases treated with mycophenolic acid: data from the French RMD COVID-19 cohortMarie-Elise Truchetet, Elodie Drumez, Thomas Barnetche, et al.
Frontiers in Immunology|July 19, 2019
Renal Pathologic Findings in TAFRO Syndrome: Is There a Continuum Between Thrombotic Microangiopathy and Membranoproliferative Glomerulonephritis? A Case Report and Literature ReviewAmélie Leurs, Viviane Gnemmi, Arnaud Lionet, et al.
British Journal of Haematology|November 20, 2002
Autologous bone marrow transplantation in the treatment of refractory systemic sclerosis: early results from a French multicentre phase I-II studyDominique Farge, Jean Pierre Marolleau, Sarah Zohar, et al.
BMC Nephrology|November 11, 2018
Early predictors of one-year mortality in patients over 65 presenting with ANCA-associated renal vasculitis: a retrospective, multicentre studyDimitri Titeca-Beauport, Alexis Francois, Thierry Lobbedez, et al.
Clinical Rheumatology|February 4, 2014
Risk factors for severe bacterial infections in patients with systemic autoimmune diseases receiving rituximabMarion Heusele, Pierre Clerson, Benoit Guery, et al.
The Journal of Rheumatology|June 3, 2009
Clinical features of scleroderma patients with or without prior or current ischemic digital ulcers: post-hoc analysis of a nationwide multicenter cohort (ItinérAIR-Sclérodermie)Kiet Phong Tiev, Elisabeth Diot, Pierre Clerson, et al.
Presse Medicale (Paris, France : 1983)|November 23, 2007
[Management of digital ulcers from systemic scleroderma]Camille Francès, Yannick Allanore, Jean Cabane, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 11, 2019
Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic SclerosisVincent Sobanski, Jonathan Giovannelli, Yannick Allanore, et al.
Pageof 51